Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Firefly Neuroscience (AIFF) EPS (Weighted Average and Diluted) (2016 - 2025)

Firefly Neuroscience has reported EPS (Weighted Average and Diluted) over the past 15 years, most recently at -$0.2 for Q3 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.2 for Q3 2025, up 67.21% from a year ago — trailing twelve months through Sep 2025 was -$1.03 (up 5.5% YoY), and the annual figure for FY2021 was -$0.09, down 400.0%.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.2 at Firefly Neuroscience, up from -$0.61 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for AIFF hit a ceiling of $0.36 in Q2 2023 and a floor of -$0.61 in Q3 2024.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.11 (2021), compared with a mean of -$0.15.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 2666.13% in 2022 and later soared 500.0% in 2023.
  • Firefly Neuroscience's EPS (Weighted Average and Diluted) stood at -$0.11 in 2021, then plummeted by 136.36% to -$0.26 in 2022, then skyrocketed by 238.46% to $0.36 in 2023, then crashed by 269.44% to -$0.61 in 2024, then surged by 67.21% to -$0.2 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.2 (Q3 2025), -$0.61 (Q3 2024), and -$0.58 (Q2 2024) per Business Quant data.